Nanoparticle drug‐delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle-Reference-Cited by-同舟云学术

Nanoparticle drug‐delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle

Published:2017-02-09 Issue:3 Volume:9 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Colby Aaron H.¹²,Oberlies Nicholas H.³,Pearce Cedric J.⁴,Herrera Victoria L.M.⁵,Colson Yolonda L.²,Grinstaff Mark W.⁶

Affiliation:

1. Departments of Biomedical Engineering and Chemistry Boston University Boston MA USA

2. Division of Thoracic Surgery, Department of Surgery Brigham and Women's Hospital Boston MA USA

3. Department of Chemistry and Biochemistry University of North Carolina at Greensboro Greensboro NC USA

4. Mycosynthetix, Inc. Hillsborough NC USA

5. Department of Medicine and Whitaker Cardiovascular Institute Boston University School of Medicine Boston MA USA

6. Departments of Biomedical Engineering, Chemistry, and Medicine Boston University Boston MA USA

Funder

National Science Foundation

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1451

Reference81 articles.

1. Intraperitoneal therapy for peritoneal cancer

2. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: State of the art and future developments

3. A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S‐1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis;Imano M;Anticancer Res,2012

4. Plasma and tissue disposition of paclitaxel (taxol) after intraperitoneal administration in mice;Innocenti F;Drug Metab Dispos,1995

5. A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Treatment of Peritoneal Metastatic Cancer and the Application of Therapeutic Nanoagents;ACS Applied Bio Materials;2023-11-02

2. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival;Biomedicine & Pharmacotherapy;2023-09

3. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance;Cancer and Metastasis Reviews;2023-07-28

4. Implantable smart hyperthermia nanofibers for cancer therapy: Challenges and opportunities;WIREs Nanomedicine and Nanobiotechnology;2023-05-31

5. Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer;Frontiers in Oncology;2023-05-23